A Clinical and Imaging Study to Evaluate a Novel Dentifrice
2 other identifiers
observational
194
1 country
1
Brief Summary
There is a need for toothpastes that more effectively remove oral biofilm, inhibit biofilm re-formation and support periodontal health. This is particularly important for patients with long-term orthodontic fixtures or prosthodontic appliances, and also for debilitated, diabetic and immunocompromised patients. The objective of this study is to evaluate the effects of toothpastes on plaque presence and removal, gingival and periodontal health, dental hard tissue mineralization, erosion, abrasion, and microstructure as well as dry/sore mouth. In addition to clinical scoring and photographs, tooth and gum sensitivity, saliva volume, pH and buffering and enamel health may be evaluated using tooth samples worn on removable dental retainers. These samples will be examined outside of the mouth using advanced optical techniques such as Optical Coherence Tomography (OCT), Fluorescence, various forms of microscopy and spectroscopy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2014
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2014
CompletedFirst Submitted
Initial submission to the registry
October 9, 2014
CompletedFirst Posted
Study publicly available on registry
October 22, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2021
CompletedSeptember 15, 2022
September 1, 2022
6.7 years
October 9, 2014
September 12, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
Gingival health measure 1
Gingival Index
Up to 6 months
Gingival health measure 2
Sulcus Bleeding Index
Up to 6 months
Gingival health measure 3
Optical Coherence Tomography
Up to 6 months
Periodontal health measure 1
Optical Coherence Tomography
Up to 6 months
Periodontal health measure 2
Periodontal Pocket Depths
Up to 6 months
Plaque removal and reaccumulation measure 1
Plaque Index
Up to 6 months
Plaque removal and reaccumulation measure 2
Optical Coherence Tomography
Up to 6 months
Plaque removal and reaccumulation measure 3
Multiphoton microscopy
Up to 6 months
Secondary Outcomes (6)
Plaque characterization
Up to 6 months
Enamel health measure 1
Up to 6 months
Enamel health measure 2
Up to 6 months
Enamel health measure 3
Up to 6 months
Enamel health measure 4
Up to 6 months
- +1 more secondary outcomes
Study Arms (1)
Oral Hygiene
Oral Hygiene
Interventions
Eligibility Criteria
Study population will be recruited from University of California Irvine faculty, staff and students as well as individuals residing or working in the UCI neighborhood.
You may qualify if:
- Male or female over the age of 18
- Have a previously diagnosed condition of gingivitis and periodontitis including gingival bleeding, gingival inflammation, plaque, and for some study sections at least four sites with probing pocket depths \> 4mm.
- Not pregnant and not lactating.
You may not qualify if:
- Participated in other clinical study within the last 30 days.
- Plan to receive dental treatment during the study dates.
- History of significant adverse effects following use of oral hygiene products such as toothpastes and mouth rinses.
- Allergies to personal care/consumer products or their ingredients.
- Less than 20 teeth (excluding third molars).
- For some studies, within six months prior to baseline, any quadrant or maintenance S/RP, and/or periodontal surgical therapy
- Diagnosed with active acquired immunodeficiency syndrome (AIDS) or Hepatitis B/C and other significant disease or disorder.
- Poorly controlled diabetes
- History of herpetic infection, recurrent aphthous ulcer, or other ulcerative diseases, abscesses, granulomas.
- History of or currently undergoing immunosuppression
- Taken antibiotics in the previous 3 months.
- Taking anti-inflammatory medications or Immunosuppressants.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of California, Irvinelead
- Livionex Inc.collaborator
Study Sites (1)
Beckman Laser Institute, University of california, Irvine
Irvine, California, 92612, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Petra Wilder-Smith, DDS, DMD, PhD
Beckman Laser Institute, UCI
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, Director of Dentistry
Study Record Dates
First Submitted
October 9, 2014
First Posted
October 22, 2014
Study Start
October 1, 2014
Primary Completion
June 1, 2021
Study Completion
June 1, 2021
Last Updated
September 15, 2022
Record last verified: 2022-09
Data Sharing
- IPD Sharing
- Will not share